# Sacha Gnjatic

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sacha-gnjatic/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,409 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 92 |
| i10-index | 248 |
| Last Known Institution | Mount Sinai Hospital |
| OpenAlex ID | https://openalex.org/A5078046623 |
| ORCID iD | https://orcid.org/0000-0001-5643-9520 |
| Works | 968 |

## Researcher papers

- [PD-L1 as a biomarker of response to immune-checkpoint inhibitors](https://scholariq.org/papers/pd-l1-as-a-biomarker-of-response-to-immune-checkpoint-inhibitors/)
- [CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma](https://scholariq.org/papers/cd8-tumor-infiltrating-lymphocytes-are-predictive-of-survival-in-muscle-invasive/)
- [Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans](https://scholariq.org/papers/recombinant-ny-eso-1-protein-with-iscomatrix-adjuvant-induces-broad-integrated/)
- [Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma](https://scholariq.org/papers/intratumoral-dendritic-cell-cd4-t-helper-cell-niches-enable-cd8-t-cell/)
- [Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City](https://scholariq.org/papers/coronavirus-2019-and-people-living-with-human-immunodeficiency-virus-outcomes/)
- [Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial](https://scholariq.org/papers/neoadjuvant-cemiplimab-for-resectable-hepatocellular-carcinoma-a-single-arm-open/)
- [Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies](https://scholariq.org/papers/serologic-response-to-messenger-rna-coronavirus-disease-2019-vaccines-in/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [vaccines and immunoinformatics approaches](https://scholariq.org/topics/vaccines-and-immunoinformatics-approaches-2/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Mount Sinai Hospital](https://scholariq.org/institutions/mount-sinai-hospital-4/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.